BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Ciprofibrate, rs2476601, LEP, calcium channel activity, HIV infection, Embryo, Alcohol)
Bookmark Forward

QuickView for ICI 182780 (compound)


Genetic Markers

Most Correlated Genes

  1. RAD51AP1
  2. CDK1
  3. ZWILCH
  4. ZNF367
  5. DTL
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. FISCHER_DREAM_TARGETS
  2. GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
  3. DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
  4. KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
  5. DODD_NASOPHARYNGEAL_CARCINOMA_DN
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Breast cancer MCF-7 cells treated with selective estrogen receptor modulators
  2. MCF7 breast cancer cells treated with tamoxifen metabolites in the presence or absence of estrogen.
  3. Uterus of COUP-TFII mutant mice treated with oil or ICI 182,780
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Effects of afala and antiestrogen ICI 182,780 in the model of hormone-dependent prostate inflammatio…
  2. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when …
  3. Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistan…
  4. Genistein versus ICI 182, 780: an ally or enemy in metastatic progression of prostate cancer.
  5. Differential effects of estrogen and estrogen receptor antagonist, ICI 182 780, on the expression of…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
  2. ICI 182780 in Treating Women With Metastatic Breast Cancer
  3. Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic …
  4. Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is …
  5. Fulvestrant or Aromatase Inhibitor and Palbociclib in Treating Older Patients With Hormone Responsiv…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.